Molecular mimicry-based repositioning of nutlin-3 to anti-apoptotic Bcl-2 family proteins

J Am Chem Soc. 2011 Feb 9;133(5):1244-7. doi: 10.1021/ja109521f. Epub 2011 Jan 6.

Abstract

The identification of off-target binding of drugs is a key to repositioning drugs to new therapeutic categories. Here we show the universal interactions of the p53 transactivation domain (p53TAD) with various anti-apoptotic Bcl-2 family proteins via a mouse double minute 2 (MDM2) binding motif, which play an important role in transcription-independent apoptotic pathways of p53. Interestingly, our structural studies reveal that the anti-apoptotic Bcl-2 family proteins and MDM2 share a similar mode of interaction with the p53TAD. On the basis of this close molecular mimicry, our NMR results demonstrate that the potent MDM2 antagonists Nutlin-3 and PMI bind to the anti-apoptotic Bcl-2 family proteins in a manner analogous to that with the p53TAD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs
  • Amino Acid Sequence
  • Apoptosis*
  • Cell Line
  • Humans
  • Imidazoles / chemistry*
  • Imidazoles / metabolism*
  • Models, Molecular*
  • Molecular Sequence Data
  • Piperazines / chemistry*
  • Piperazines / metabolism*
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins c-bcl-2 / chemistry*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Proto-Oncogene Proteins c-mdm2 / metabolism
  • Tumor Suppressor Protein p53 / chemistry
  • Tumor Suppressor Protein p53 / metabolism
  • bcl-X Protein / chemistry
  • bcl-X Protein / metabolism

Substances

  • Imidazoles
  • Piperazines
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • bcl-X Protein
  • nutlin 3
  • Proto-Oncogene Proteins c-mdm2